Reze, France

Bernard Vanhove

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 79(Granted Patents)


Location History:

  • Rezé, FR (2022)
  • Reze, FR (2010 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Bernard Vanhove: A Pioneer in Cell Therapy Innovations

Introduction

Bernard Vanhove, based in Reze, France, is a notable inventor with a remarkable portfolio of 20 patents. His work focuses on cutting-edge advancements in cell therapy, particularly through the development of innovative methods involving T effector cells. This article delves into his latest patents, career highlights, and collaborations that have significantly impacted the field of medical research.

Latest Patents

Among Bernard Vanhove's notable inventions is a method for isolating T effector cells from human leukocytes using anti-CD127 antibodies. This invention is instrumental in selectively depleting subpopulations of T regulatory cells expressing CD127 at low levels in human T lymphocytes. The ability to recover T effector cells, free from T regulatory cells, enhances the efficacy of therapies administered to patients.

Another significant patent focuses on anti-SIRPa antibodies, which specifically antagonize the interaction between SIRPa and CD47, while preserving the essential interactions of SIRPg. These antibodies open new avenues for therapeutic applications, contributing to advancements in cancer treatments and immunotherapy.

Career Highlights

Bernard has made significant contributions through his work with Ose Immunotherapeutics, where he helped steer innovative cell therapy projects. Additionally, his role at the Institut National De La Sante Et De La Recherche Medicale has been instrumental in tackling pressing health challenges through research and innovation.

Collaborations

Throughout his career, Bernard Vanhove has worked alongside notable colleagues such as Caroline Mary and Nicolas Poirier. Their combined expertise has fostered an environment conducive to groundbreaking research and the development of innovative therapies.

Conclusion

Bernard Vanhove stands out as a leading inventor in the realm of cell therapy, with a robust portfolio that demonstrates his commitment to medical innovation. His latest patents not only highlight his inventive capabilities but also contribute significantly to advances in therapeutic applications. As the field evolves, his work will likely continue to influence future developments in immunotherapy and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…